Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland
Citations Over TimeTop 10% of 2002 papers
Abstract
PTEN tumor suppressor is frequently mutated in human cancers, including breast cancers. Female patients with inherited PTEN mutations suffer from virginal hypertrophy of the breast with high risk of malignant transformation. However, the exact mechanisms of PTEN in controlling mammary gland development and tumorigenesis are unclear. In this study, we generated mice with a mammary-specific deletion of the Pten gene. Mutant mammary tissue displayed precocious lobulo-alveolar development, excessive ductal branching, delayed involution and severely reduced apoptosis. Pten null mammary epithelial cells were disregulated and hyperproliferative. Mutant females developed mammary tumors early in life. Similar phenotypes were observed in Pten-null mammary epithelia that had been transplanted into wild-type stroma, suggesting that PTEN plays an essential and cell-autonomous role in controlling the proliferation, differentiation and apoptosis of mammary epithelial cells.
Related Papers
- → Subtle variations in Pten dose determine cancer susceptibility(2010)574 cited
- Loss of PTEN promotes tumor development in malignant melanoma.(2003)
- → Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis(2014)127 cited
- → Infrequent hypermethylation of the PTEN gene in Korean non‐small‐cell lung cancers(2009)9 cited
- The Study of Tumor Suppressor Gene PTEN in the Carcinoma of Urinary System(2009)